Authors: | Armstrong, A. J.; Antonarakis, E. S.; Taplin, M. E.; Kelly, W. K.; Beltran, H.; Fizazi, K.; Dahut, W. L.; Shore, N.; Slovin, S.; George, D.; Carducci, M. A.; Corn, P.; Danila, D.; Dreicer, R.; Heath, E.; Rathkopf, D.; Liu, G.; Nanus, D.; Stein, M.; Smith, M. R.; Sternberg, C.; Wilding, G.; Nelson, P. S.; Halabi, S.; Kantoff, P.; Clarke, N. W.; Evans, C. P.; Heidenreich, A.; Mottet, N.; Gleave, M.; Morris, M. J.; Scher, H. I. |
Article Title: | Naming disease states for clinical utility in prostate cancer: A rose by any other name might not smell as sweet |
Keywords: | cancer patient; homologous recombination; editorial; prostate cancer; patient care; nomenclature; testosterone blood level; testosterone; personalized medicine; castration resistant prostate cancer; human; priority journal; medical terminology |
Journal Title: | Annals of Oncology |
Volume: | 29 |
Issue: | 1 |
ISSN: | 0923-7534 |
Publisher: | Oxford University Press |
Date Published: | 2018-01-01 |
Start Page: | 23 |
End Page: | 25 |
Language: | English |
DOI: | 10.1093/annonc/mdx648 |
PROVIDER: | scopus |
PUBMED: | 29088323 |
PMCID: | PMC6248721 |
DOI/URL: | |
Notes: | Editorial -- Export Date: 1 March 2018 -- Source: Scopus |